Thema
Antineoplastic Agents, Immunological
2
Journal Article
2
31YO63LBSN
1
Antibodies, Monoclonal, Humanized
1
Atezolizumab
1
Comparative Study
1
DPT0O3T46P
1
Extended-interval dosing
1
Immune-related adverse event
1
Immunotherapy
1
Multicenter Study
1
Nivolumab
1
PD-1
1
PD-L1
1
PDCD1 protein, human
1
Patient-physician preference
1
Programmed Cell Death 1 Receptor
1
Real-world outcomes
1
Research Support, N.I.H., Extramural
1
Treatment delays
1
pembrolizumab
1